Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts-Reference-Cited by-同舟云学术

Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts

Published:2012-02-25 Issue:6 Volume:31 Page:973-981
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Brown Monica,Postlethwaite Arnold E.,Myers Linda K.,Hasty Karen A.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://www.springerlink.com/index/pdf/10.1007/s10067-012-1962-z

Reference35 articles.

1. Atamas SP, Luzina IG, Ingels J et al (2010) Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma). Clin Exp Immunol 161:426–435

2. Peterson LS, Nelson AM, Su WP (1995) Classification of morphea (localized scleroderma). Mayo Clin Proc 70:1068–1076

3. Johnson SR, Laxer RM (2006) Classification in systemic sclerosis. J Rheumatol 33:840–841

4. Fett N, Werth VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 64:217–228, quiz 29-30

5. Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME (2008) The immunobiology of systemic sclerosis. Semin Arthritis Rheum 38:132–160

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs);International Journal of Molecular Sciences;2023-09-22

2. Modulation by 17,20S(OH)2pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis;International Journal of Molecular Sciences;2021-12-29

3. Distinct Metalloproteinase Expression and Functions in Systemic Sclerosis and Fibrosis: What We Know and the Potential for Intervention;Frontiers in Physiology;2021-08-27

4. Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis;Frontiers in Immunology;2020-03-10

5. Interleukin-13: A promising therapeutic target for autoimmune disease;Cytokine & Growth Factor Reviews;2019-02